Cargando…
Depot-Based Delivery Systems for Pro-Angiogenic Peptides: A Review
Insufficient vascularization currently limits the size and complexity for all tissue engineering approaches. Additionally, increasing or re-initiating blood flow is the first step toward restoration of ischemic tissue homeostasis. However, no FDA-approved pro-angiogenic treatments exist, despite the...
Autores principales: | Van Hove, Amy H., Benoit, Danielle S. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504170/ https://www.ncbi.nlm.nih.gov/pubmed/26236708 http://dx.doi.org/10.3389/fbioe.2015.00102 |
Ejemplares similares
-
Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications
por: Liu, Mingpeng, et al.
Publicado: (2021) -
Controlled released naringin-loaded liposome/sucrose acetate isobutyrate hybrid depot for osteogenesis in vitro and in vivo
por: Meng, Di, et al.
Publicado: (2023) -
Anticoagulants Interfere With the Angiogenic and Regenerative Responses Mediated by Platelets
por: Oneto, Paula, et al.
Publicado: (2020) -
Editorial: Delivery systems in biologics-based therapeutics
por: Dirisala, Anjaneyulu, et al.
Publicado: (2023) -
Nanofiber-Based Delivery of Bioactive Lipids Promotes Pro-regenerative Inflammation and Enhances Muscle Fiber Growth After Volumetric Muscle Loss
por: San Emeterio, Cheryl L., et al.
Publicado: (2021)